Poster | 2019 ASCO Annual Meeting | TMB Standardization by Alignment to Reference Standards
Poster | 2022 ISLB Annual Congress | Collaborative Meta-analytical Approaches to Advance the Use of ctDNA in Clinical Cancer Research: The Friends of Cancer Research ctMoniTR Project
Poster | 2022 AMP Annual Meeting | Assessing Variability Across HRD Assays: Findings from the Friends’ HRD Harmonization Project
Poster | 2023 AACR Annual Meeting | Findings from the Friends of Cancer Research HRD Harmonization Project
Poster | 2023 ASCO Annual Meeting | Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets
Poster | 2023 ASCO Annual Meeting | Changes in ctDNA levels as an early indicator of outcomes in advanced NSCLC treated with TKI: Initial findings from a retrospective aggregate analysis of 8 clinical trials
Poster | 2023 ASCO Annual Meeting | Impact of COVID-19 pandemic mitigation strategies on industry and NCI cancer treatment trials.
Background: The onset of the COVID-19 pandemic resulted in major disruptions in enrollment and conduct of cancer clinical trials. In response, regulators allowed modifications to traditional trial processes to enable clinical research and care to continue. The American Society of Clinical Oncology and Friends of Cancer Research established a task force to evaluate how sponsors…
